title: Raltegravir and rifampicin in patients with HIV and tuberculosis.
authors.affiliation: University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, 9713 GZ, Netherlands. Electronic address: s.klis@umcg.nl.
authors.forename: Sandor
authors.initials: S
authors.lastname: Klis
authors.affiliation: Department of Clinical Pharmacy and Pharmacology, Groningen, 9713 GZ, Netherlands.
authors.forename: Alper
authors.initials: A
authors.lastname: Daskapan
authors.affiliation: Department of Pulmonology and Tuberculosis, Groningen, 9713 GZ, Netherlands.
authors.forename: Onno W
authors.initials: OW
authors.lastname: Akkerman
authors.affiliation: Department of Clinical Pharmacy and Pharmacology, Groningen, 9713 GZ, Netherlands.
authors.forename: Jan-Willem
authors.initials: JW
authors.lastname: Alffenaar
authors.affiliation: University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, 9713 GZ, Netherlands.
authors.forename: Ymkje
authors.initials: Y
authors.lastname: Stienstra
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D011760:Pyrrolidinones / Q000008:administration & dosage*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents; D011760:Pyrrolidinones